MedPath

Vexasyn

Vexasyn GelPrescription Only | Rx Only

Approved
Approval ID

741d022f-954f-4686-b60e-08337235e9a7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2018

Manufacturers
FDA

Sterling-Knight Pharmaceuticals, LLC

DUNS: 079556942

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vexasyn

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69336-831
Application NumberK020540
Product Classification
M
Marketing Category
C80442
Product Specifications
Effective DateJuly 30, 2018
FDA Product Classification

INGREDIENTS (9)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM ALGINATEInactive
Code: C269C4G2ZQ
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)Inactive
Code: R33S7TK2EP
Classification: IACT
LIDOCAINE HYDROCHLORIDEInactive
Code: V13007Z41A
Classification: IACT
BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT
TROLAMINEInactive
Code: 9O3K93S3TK
Classification: IACT
ALOE VERA LEAFInactive
Code: ZY81Z83H0X
Classification: IACT
BOVINE TYPE I COLLAGENInactive
Code: FHJ3ATL51C
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vexasyn - FDA Drug Approval Details